Stop-smoking drug increases users' risk of a heart attack
Stop-smoking drug increases users' risk of a heart attack - Hallo World !!! News Today in World, In this article you read by title Stop-smoking drug increases users' risk of a heart attack, We've prepared this article well so you can read and retrieve information on it. Hopefully the contents of the post
Article Salisbury News, What we write can you understand. Okay, happy reading.
Title : Stop-smoking drug increases users' risk of a heart attack
link : Stop-smoking drug increases users' risk of a heart attack
You are now reading the article Stop-smoking drug increases users' risk of a heart attack With link address https://newstoday-ok.blogspot.com/2017/12/stop-smoking-drug-increases-users-risk.html
Title : Stop-smoking drug increases users' risk of a heart attack
link : Stop-smoking drug increases users' risk of a heart attack
news-today.world | A stop-smoking drug increases users' risk of a heart attack by up to 34 percent, new research suggests.
Varenicline, which is prescribed under the brand name Chantix in the US and Champix in Europe, significantly raises users' chances of being hospitalized or visiting an emergency room for a cardiovascular-related event even if it is taken for the recommended 12 weeks, a Canadian study found.
The drug is also linked to self-harm and depression in older users, the research adds.
Previous research suggests this is due to varenicline's action on receptors found in tissues throughout the body.
Varenicline increases a smoker's chances of quitting by nearly three times by reducing nicotine cravings and blocking the rewarding effects of smoking.
A 12-week course of varenicline is one of the most effective ways to help people quit smoking, according to the NHS' website.
It says the drug is safe for most people to take and does not mention its cardiovascular or neuropsychiatric side effects aside from insomnia and vivid dreams.
More
Varenicline, which is prescribed under the brand name Chantix in the US and Champix in Europe, significantly raises users' chances of being hospitalized or visiting an emergency room for a cardiovascular-related event even if it is taken for the recommended 12 weeks, a Canadian study found.
The drug is also linked to self-harm and depression in older users, the research adds.
Previous research suggests this is due to varenicline's action on receptors found in tissues throughout the body.
Varenicline increases a smoker's chances of quitting by nearly three times by reducing nicotine cravings and blocking the rewarding effects of smoking.
A 12-week course of varenicline is one of the most effective ways to help people quit smoking, according to the NHS' website.
It says the drug is safe for most people to take and does not mention its cardiovascular or neuropsychiatric side effects aside from insomnia and vivid dreams.
More
That's an article Stop-smoking drug increases users' risk of a heart attack
Fine for article Stop-smoking drug increases users' risk of a heart attack This time, hopefully can benefit for you all. Well, see you in other article postings.
You are now reading the article Stop-smoking drug increases users' risk of a heart attack With link address https://newstoday-ok.blogspot.com/2017/12/stop-smoking-drug-increases-users-risk.html